Law firm · Switzerland

Schellenberg Wittmer

Deals
1
Latest
Jul 2026
Compare

Deals

US deals dated after 30 September 2026 are still being collected.

Columns
Deal size
Custom range

1 of 1 deals

Deals Schellenberg Wittmer advised on, most recent first
Advisers
Jul 2026 PolyPeptide Group AG –Samsung Biologics Co.AcquisitionLegal adviser to Samsung Biologics (acquirer)Announced1,454.0Pharma Services+2 J.P. Morgan (buy-side)EY (buy-side)O'Melveny & Myers (buy-side) Samsung Biologics Co. acquisition of PolyPeptide Group AG

Offices and contact

Contact

From the firm's own website.

Suggest a correction

A missing deal, a wrong role or an office to add. A link to a public source helps.